Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

VPAC receptor-specific Cu-67-TP-3805 shows theranostic potential for prostate cancer

June 23, 2022

FGFR and PDGFR as targets for CNS tumors with BCOR alterations

June 23, 2022

Biodistribution and efficacy of [177Lu]rhPSMA-10.1 compared to [177Lu]PSMA-I&T in prostate cancer

June 23, 2022

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

June 22, 2022

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

June 22, 2022

KLF5 as novel therapeutic target to reduce tumorigenic GBM phenotype

June 22, 2022

Use of [177Lu]Lu-CCZ01158 shows promise for the treatment of human melanoma

June 21, 2022

New cyclin-dependent kinase inhibitors divulged by Allorion Therapeutics

June 21, 2022

Hangzhou Polymed Biopharmaceuticals identifies new G12C mutant KRAS inhibitors

June 21, 2022

Medulloblastoma murine model dissects its poorly known biology

June 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...